Background and Purpose—Cerebral venous thrombosis is generally treated with
anticoagulation. However, some patients do not respond to medical therapy and these might …

Cerebral sinus venous thrombosis (CSVT) is a rare phenomenon that can be seen with
some frequency in young patients. CSVT is a multifactorial condition with gender-related …

Tissue plasminogen activator (tPA) is the only FDA approved medical treatment for the
ischaemic stroke. However, it associates with some inevitable limitations, including: short …

Small retrospective studies have shown the benefit of endovascular treatment with intrasinus
thrombolysis (IST) or mechanical thrombectomy (MT) with/without IST (MT+/− IST) in cases …

Introduction Cerebral venous sinus thrombosis (CVST) is an uncommon but fatal cause of
stroke worldwide. Endovascular treatments could be life-saving in patients who don't treat …

Dural venous sinus thrombosis (DVST) is a rare cause of stroke, which typically affects
young women. The importance of identifying pre-disposing factors that lead to venous stasis …

Data from large case series of children with cerebral thrombotic events are pivotal to
improve prevention, early recognition and treatment of these conditions. The Italian Registry …

Background In patients who have failed systemic anticoagulation therapy, various
endovascular approaches may assist in emergent recanalization. Methods We searched the …

Aim: We experienced a series of patients with hemorrhagic CVST, who were successfully
treated with endovascular treatment (EVT). The aim was to explore the best scheme for the …

The present study aimed to summarize the clinical characteristics and experiences of
misdiagnoses of cerebral venous thrombosis (CVT). A total of 18 patients with CVT who …